Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells

Mutagenesis

Volumn 13, Issue 5, 1998, Pages 427-434

  Clark, L Scott ^a,d   Hart, Daniel W ^b   Vojta, Patrick J ^b   Harrington Brock, Karen ^c   Barrett, J Carl ^b   Moore, Martha M ^c   Tindall, Kenneth R ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d Environ Carcinogenesis Division

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CHROMOSOME 11; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE LOCATION; GENETIC LINKAGE; HETEROZYGOSITY; LYMPHOMA CELL; MISSENSE MUTATION; MOLECULAR CLONING; MOUSE; MOUSE MUTANT; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STOP CODON;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CODON; CODON, NONSENSE; DNA, NEOPLASM; EXONS; GENES, P53; LEUKEMIA L5178; LINKAGE (GENETICS); MICE; MOLECULAR SEQUENCE DATA; MUTAGENICITY TESTS; MUTATION, MISSENSE; NEOPLASM PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; THYMIDINE KINASE;

ANIMALIA;

EID: 0031671043     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/13.5.427     Document Type: Article

References (37)

1. Applegate,M. and Hozier,J. (1989) On the complexity of mutagenic events at the mouse lymphoma Tk locus. In Moore,M., Demarini,D., deSerres,F. and Tindall,K. (eds), Mammalian Cell Mulagenesis; Banbury Report No. 28. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, Vol. 28, pp. 213-224.
2. Applegate,M. et al. (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc. Natl Acad. Sci. USA, 87, 51-55.
3. Bates,S. and Vousden,K. (1996) p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6, 12-19.
4. Cho,Y., Gorina,S., Jeffrey,P. and Pavletich,N. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
5. Culotta,E. and Koshland,D. (1993) p53 sweeps through cancer research. Science. 262.
6. Dearfield,K., Auletta,A., Cimino,M. and Moore,M. (1991) Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat. Res., 258, 259-283.
7. DHHS (1997) International Conference on Harmonisation; Draft Guidelines on Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. Food and Drug Administration, Rockville, MD.
8. Duvall,E. and Wyllie,A. (1987) Death and the cell. Immunol, Today, 7,115-119.
9. Evans,H. et al. (1986) Locus specificity in the mutability of L5178Y mouse lymphoma cells: the role of multilocus lesions. Proc. Natl Acad. Sci. USA, 83, 4379-4383.
10. Gannon,J., Greaves,R., Iggo,R. and Lane,D. (1990) Activating mutation in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J., 9, 1959-1602.
11. Hainaut,P. (1995) The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol., 7, 76-82.
12. Harlow,E., Crawford,L., Pim,D. and Williamson,N. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigen. J. Virol., 39: 861-869.
13. Harvey,D. and Levine,A. (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5, 2375-2385.
14. Hegi,M. et at. (1993) Characterization of p53 mutations in methylene chlorideinduced lung tumors from B6C3F1 mice. Carcinogenesis, 14, 803-810.
15. Hozier,J. et al (1991) Localization of the mouse thymidine kinase gene to the distal portion of chromosome 11. Genomics, 10, 827-830.
16. Hozier,J., Applegate,M. and Moore,M. (1992) In vitro mammalian mutagenesis as a model for genetic lesions in human cancer. Murat. Res., 270, 201-209.
17. Hsie,A. et al. (1986) Evidence for reactive oxygen species inducing mutations in mammalian cells. Proc. Natl Acad. Sci. USA, 83, 9616-9620.
18. Kuerbitz,S., Plunkett,B., Walsh,W. and Kastan,M. (1992) Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89, 7491-7495.
19. Lane,D. (1992) p53, guardian of the genome. Nature, 358, 15-16.
20. Little,J., Yandell,D. and Liber,H. (1987) Molecular analysis of mutations at the TK and HPRTloci in human cells. In Moore,M., Demarini,D., deSerres,F. and Tindall,K. (eds). Mammalian Cell Mutagenesis; Banbury Report No. 28. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 225-236.
21. Mitchell,A. (1997) Alternate hypothesis for the bimodal distribution of mutant colonies of L5178Y mouse lymphoma cells. Environ. Mol. Mutagen., 29, 431-433.
22. +\- mouse lymphoma specific gene and chromosomal mutation assay: a phase III report of the US Environmental Protection Agency Gene-Tox Program. Mutat. Res., 394, 177-303.
23. Moore,M., Brock,K., DeMarini,D. and Doerr,C. (1986) Differential recovery of induced mutants at the Tk and Hgprt loci in mammalian cells. In Moore,M., Demarini,D., deSerres,F. and Tindall,K. (eds), Mammalian Cell Mutagenesis; Banbury Report No. 28. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 93-108.
24. Moore,M., Harrington-Brock,K., Doerr,C. and Dearfield,K. (1989) Differential mutant quantitation at the mouse lymphoma Tk and CHO Hgprt loci. Mutagenesis, 4, 394-403.
25. +\- mouse lymphoma cells. Mutat. Res., 85, 363-378.
26. Orita,M., Suzuki,Y., Sekiya,T. and Hayashi,K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
27. Soussi,T., Caron de Fromentel,C. and May,P. (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952.
28. Stankowski,L. and Hsie,A. (1986) Quantitative and molecular analyses of radiation-induced mutations in AS52 cells. Radiat. Res., 105, 37-48.
29. +\- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat. Res., 373, 157-165.
30. Tan,T.-H., Wallis,J. and Levine,A. (1986) Identification of the p53 protein domain involved in formation of the simian virus 40 large T antigen p53 protein complex. J. Virol., 59, 574-583.
31. Tennant,R. et al. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
32. -\- mouse lymphoma assay. In Kilbey,B., Legator,M. and Ramel,C. (eds), Handbook of Mutagenicity Test Procedures. Elsevier, Amsterdam, The Netherlands, pp. 239-268.
33. Ullrich,S., Anderson,C., Mercer,W. and Appella,E. (1995) The p53 tumor suppressor protein, a modulator of proliferation. J. Biol. Chem., 267, 15259-15262.
34. Wyllie,A. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
35. Yandell,D., Dryja,T. and Little,J. (1986) Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations. Somatic Cell Mol. Genet., 12, 255-263.
36. Yewdell,J., Gannon,J. and Lane,D. (1986) Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol., 59, 444-452.
37. Zeiger,E., Haseman,J., Shelby,M., Margolin,B. and Tennant,R. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen., 16, 1-14.